Progress Toward a Malaria Vaccine
- 15 September 1990
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 25 (9) , 45-57
- https://doi.org/10.1080/21548331.1990.11703995
Abstract
In initial human trials, synthetic vaccines have induced humoral immunity sufficient to prevent clinical infection in some cases and delay it in others. Progress in induction of cellular immunity is also noteworthy with identification of determinants recognized by T cells. Antigenic variation and consequent blunting of immunogenicity may not be as troublesome as feared.Keywords
This publication has 6 references indexed in Scilit:
- Conserved Repetitive Epitope Recognized by CD4 + Clones From a Malaria-Immunized VolunteerScience, 1989
- Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malariaNature, 1989
- Rationale for the Development of an Engineered Sporozoite Malaria VaccinePublished by Elsevier ,1989
- A malaria T-cell epitope recognized in association with most mouse and human MHC class II moleculesNature, 1988
- The T Cell Response to the Malaria Circumsporozoite Protein: An Immunological Approach to Vaccine DevelopmentAnnual Review of Immunology, 1988
- Inhibition of Development of Exoerythrocytic Forms of Malaria Parasites by γ-InterferonScience, 1986